Domet (Tablets) Instructions for Use
Marketing Authorization Holder
Protech Biosystems, Pvt. Ltd. (India)
ATC Code
A03FA03 (Domperidone)
Active Substance
Domperidone (Rec.INN registered by WHO)
Dosage Form
| Domet | Tablets 10 mg: 10, 30 or 100 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Domperidone | 10 mg |
10 pcs. – blister packs (1) – cardboard packs.
10 pcs. – blister packs (3) – cardboard packs.
10 pcs. – blister packs (10) – cardboard packs.
Clinical-Pharmacological Group
Centrally acting antiemetic drug blocking dopamine receptors
Pharmacotherapeutic Group
Antiemetic agent – central dopamine receptor antagonist
Pharmacological Action
Antiemetic agent. It has an antiemetic effect, soothes hiccups and in some cases eliminates nausea.
The action is due to the blockade of central dopamine receptors. This eliminates the inhibitory effect of dopamine on the motor function of the gastrointestinal tract and increases the evacuation and motor activity of the stomach.
Pharmacokinetics
Absorption after oral administration on an empty stomach is rapid (administration after a meal, reduced gastric acidity slow down and reduce absorption).
Cmax is reached in 1 h. Bioavailability is 15% (first-pass effect through the liver). Plasma protein binding is 90%.
It penetrates into various tissues, poorly passes through the BBB. It is metabolized in the liver and in the intestinal wall (by hydroxylation and N-dealkylation).
It is excreted through the intestine 66%, by the kidneys – 33%, including unchanged – 10% and 1%, respectively. T1/2 – 7-9 h, in severe chronic renal failure – it is prolonged.
Indications
Nausea, vomiting, hiccups of various origins (in toxemia, radiation therapy, dietary disorders, intake of certain drugs /morphine/, endoscopic and radiopaque studies, in the postoperative period).
Postoperative hypotension and atony of the stomach and intestines, biliary dyskinesia, flatulence, reflux esophagitis, cholecystitis, cholangitis, various types of dyspepsia.
Nausea and vomiting caused by the intake of dopaminomimetics.
ICD codes
| ICD-10 code | Indication |
| K21.0 | Gastro-esophageal reflux disease with esophagitis |
| K30 | Functional dyspepsia (digestive disorder) |
| K31.8 | Other specified diseases of stomach and duodenum |
| K59.8 | Other specified functional intestinal disorders |
| K81.0 | Acute cholecystitis |
| K81.1 | Chronic cholecystitis |
| K82.8 | Other specified diseases of gallbladder and cystic duct (including dyskinesia) |
| K83.0 | Cholangitis |
| R06.6 | Hiccough |
| R11 | Nausea and vomiting |
| R14 | Flatulence and related conditions (including abdominal bloating, belching) |
| ICD-11 code | Indication |
| DA22.Z | Gastro-esophageal reflux disease, unspecified |
| DA24.Z | Unspecified esophagitis |
| DA40.2 | Volvulus of stomach |
| DA41.0Z | Unspecified disorder of stomach motility |
| DA41.2 | Acid hyper secretion |
| DA41.3 | Achlorhydria |
| DA43.1 | Angiodysplasia of stomach |
| DA43.2 | Arteriovenous malformation of the stomach |
| DA43.3 | Gastropathy in portal hypertension |
| DA43.4 | Diffuse gastric vascular ectasia |
| DA4Y | Other specified diseases of the stomach |
| DA50.3 | Deformation of duodenum, acquired |
| DA52.1 | Angiodysplasia of duodenum |
| DA52.2 | Arteriovenous malformation of duodenum |
| DA52.Y | Other specified vascular diseases of duodenum |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DB32.3 | Acquired hypoganglionosis of the colon |
| DB32.Z | Colonic motility disorders, unspecified |
| DC12.0Z | Acute cholecystitis, unspecified |
| DC12.1 | Chronic cholecystitis |
| DC13 | Cholangitis |
| DC1Z | Diseases of gallbladder and biliary tract, unspecified |
| DD90.0 | Globus sensation |
| DD90.1 | Functional dysphagia |
| DD90.2 | Functional heartburn |
| DD90.3 | Functional dyspepsia |
| DD90.Z | Functional disorders of esophagus or gastroduodenal system, unspecified |
| DD91.Y | Other specified irritable bowel syndrome or functional bowel disorders |
| DD93.Y | Other specified functional gastrointestinal disorders in infants, toddlers and school-age children |
| DD94 | Functional disorder of the gallbladder |
| MD11.6 | Hiccough |
| MD90 | Nausea or vomiting |
| ME08 | Flatulence and related conditions |
| ME24.3Y | Other specified perforation in the area of the gastrointestinal tract |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally.
Take tablets 15-30 minutes before meals.
For adults and adolescents 12 years and older (with body weight of 35 kg or more), the usual dose is 10 mg (one tablet) three to four times daily.
Do not exceed a maximum daily dose of 40 mg (four tablets).
The duration of treatment should not exceed one week for nausea and vomiting.
For children from 5 to 11 years of age (with body weight of 20-34 kg), use only if specifically indicated and under medical supervision.
The pediatric dose for this age group is 5 mg (half a 10 mg tablet) three times daily.
Do not exceed a maximum daily dose of 15 mg for children in this group.
This drug is contraindicated in children under 5 years of age and in children weighing less than 20 kg.
In patients with severe renal impairment (serum creatinine >6 mg/100 ml), reduce the dosing frequency to once or twice daily.
In patients with hepatic impairment, use with caution and consider dose reduction.
Adverse Reactions
From the CNS rarely – increased excitability and/or extrapyramidal disorders, headache.
From the digestive system spasms of the smooth muscles of the gastrointestinal tract, dry mouth, thirst.
Allergic reactions itching, rash, urticaria.
Other increased plasma prolactin levels, galactorrhea, gynecomastia.
Contraindications
Gastrointestinal bleeding, mechanical intestinal obstruction, perforation of the stomach or intestines, prolactinoma, pregnancy, lactation (breastfeeding), hypersensitivity to domperidone; children under 12 years of age and body weight less than 35 kg (for tablets).
Use in Pregnancy and Lactation
Domperidone is contraindicated for use during pregnancy and lactation.
Use in Hepatic Impairment
It should be used with caution in case of liver function disorders.
Use in Renal Impairment
It should be used with caution in case of renal function disorders. In renal failure, the frequency of administration should be reduced.
Pediatric Use
Contraindicated in children under 1 year of age (under 5 years of age and children weighing less than 20 kg – for tablets).
Special Precautions
It should be used with caution in case of liver and kidney function disorders.
Drugs containing Domperidone should be administered to children in dosage forms intended for the appropriate age.
Drug Interactions
When used simultaneously with antacids, antisecretory drugs (including cimetidine, sodium bicarbonate), the bioavailability of domperidone decreases.
When used simultaneously with anticholinergic drugs, the effect of domperidone is suppressed.
Since Domperidone is metabolized mainly with the participation of the CYP3A4 isoenzyme, it is believed that with the simultaneous use of domperidone and inhibitors of this isoenzyme (including azole antifungals, macrolide antibiotics, HIV protease inhibitors, nefazodone), an increase in the plasma level of domperidone is possible.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
OKI, sachets 80mg 2g, 12pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Cortexin, 10mg, 5ml, 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
Kagocel pills 12mg, 30pcs
Actovegin pills 200mg, 50pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Belosalic, lotion solution for external use spray 100ml
Ingavirin capsules 90mg, 10pcs 